By

Luke Timmerman

12
Mar
2019

Seeing Lots of Single Cells, Up Close: Serge Saxonov of 10X Genomics on The Long Run

Serge Saxonov is today’s guest on The Long Run. Serge is the co-founder and CEO of Pleasanton, California based 10X Genomics. This privately held company, in a nutshell, is a fast-growing supplier for the genomics revolution. 10X, for those unfamiliar, makes instruments, chemical reagents for running experiments, and software that helps scientists collect and analyze various types of data. The...
Read More
27
Feb
2019

Staying Resilient, Finding a Way Forward: Julia Owens on The Long Run

Julia Owens is today’s guest on The Long Run. Owens is the CEO of Ann Arbor, Michigan-based Millendo Therapeutics. This company develops drugs for rare endocrine disorders. Prader-Willi syndrome, a terrible genetic disorder that causes young people to develop voracious appetites and which leads to severe obesity, is the focus of the company’s lead drug candidate. It’s entering a pivotal...
Read More
20
Feb
2019

The Boston Cancer Summit and SF Cancer Summit. See the Agenda & Get Your Tickets

The Boston Cancer Summit is loaded with a stellar lineup of speakers on Apr. 16. Same deal with the San Francisco Cancer Summit on Apr. 18. I’m excited to announce the agendas for these special idea-and-networking forums. Hal Barron of GSK, David Schenkein of GV, Cindy Perettie of Foundation Medicine, and Ira Mellman of Genentech are a few of the...
Read More
12
Feb
2019

The Immune Sequencing Frontier (Take 2): Harlan and Chad Robins on The Long Run

Today’s guests on The Long Run are Harlan and Chad Robins. They are brothers and co-founders of Seattle-based Adaptive Biotechnologies. Chad is the CEO, and Harlan is the head of innovation. Harlan is also a faculty member at the Fred Hutchinson Cancer Research Center just down the street from Adaptive. Senior people in pharma R&D are quite familiar with Adaptive....
Read More
6
Feb
2019

Get Tickets Now: The Cancer Summit Series is Coming to Boston, SF, Seattle

We live in a time of tremendous possibility for cancer R&D. Checkpoint inhibitors, cell therapies, molecular diagnostics that catch cancer early and can guide effective custom treatment – these fields are brimming with progress. All were considered speculative at best a decade ago. The science has never been more promising. Yet pricing and access to this new world of cancer...
Read More
30
Jan
2019

Finding a Way in Genomic Diagnostics: Bonnie Anderson of Veracyte on The Long Run

Bonnie Anderson is today’s guest on The Long Run. Bonnie is the CEO of Veracyte. It’s a genomic diagnostics company in South San Francisco. The company markets a line of tests for thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. Veracyte got started in 2008. Bonnie, as co-founder and CEO, was recruited by Kleiner Perkins Caufield & Byers and a...
Read More
1 2 3 23